As ‘Covaxin’ gets a nod from WHO, India expects more nations to give emergency approval

Delhi-On November 3, World Health Organization (WHO) gave emergency use approval for coronavirus to India’s first indigenous jab, Bharat Biotech’s ‘Covaxin’ vaccine.

Hyderabad-based Bharat Biotech International Limited manufactures Covaxin. It is among six vaccines used for the nationwide inoculation drive, which started on January 16 in India. Alongside the Covishield vaccine, it is the most broadly used injection for the covid-19 immunization drive. 

As most nations have opened their borders for completely immunized travellers, the Swiss government has published a list of vaccines in which they have also recognized Covaxin for international travel.

As the Ministry of External Affairs (MEA) is having conversations with global counterparts from various nations over Covaxin permission, India’s strategic missions, as well, are conversing with their host countries to gain their consent.

After the emergency use listing (EUL) by WHO for Covaxin, MEA is reaching out to get a green signal from more nations like the UK, other European countries, and Canada.

Related Posts

• After much delay, Covaxin gets WHO’s approval
• CoWIN App: Over 12 Nations in Discussions with Modi Govt to Borrow the Technology
• Covaxin Efficacy Determined At 50Percent: First World Study
• Cracks in Hinduja Group as conglomerate faces family feud
• Health Minister: Children to get Covid-19 vaccine likely from next month
• India Presents Vaccine Agenda And Climate Sensitivity At COP26 G20 Summit
• Monthly production to see surge: Covishield to reach 120 million, Covaxin to 58 million per month
• Omicron Virus: India’s Union Health Ministry Updates Covid Guideline for International Passengers
• UK to end quarantine for Indians who are vaccinated with Covidshield
• WHO Chief Scientist says that India might be entering the pandemic stage of COVID-19

According to the Canadian High Commission, the Coronavirus medicine and vaccine entries are evaluated and prioritized quickly over the standard performance principles because of the general public health requirement…However, the timing for the completion of Health Canada’s report relies upon many variables. 

As per a Hindustan Times report, at present, a few nations have permitted completely inoculated Indian nationals to enter without necessary quarantine upon entry into their country. 

Covaxin, then again, has received endorsement from nearly twelve nations. However, many of these nations expect travellers inoculated with Covishield, the Indian variation of Britain’s AstraZeneca injection. From November 8, the United States will also permit entry of travellers vaccinated with Covaxin. 

Coronavirus vaccine Covaxin approval is critical to getting more extensive worldwide permission to the indigenously manufactured vaccine.